AJNN
Academic Journal of Neurology and Neurosurgery

The Academic Journal of Neurology and Neurosurgery deals with Neurology and Neurosurgery accepts articles on these topics. Academic Journal of Neurology and Neurosurgery publishes original research articles, review articles, case reports, editorial commentaries, letters to the editor, educational articles, and conference/meeting announcements.

eISSN: 3023-6517
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
The role of hemogram parameters in predicting diabetic neuropathy risk in patients follow-up with type 2 diabetes mellitus
Abstract
Aims: Neuropathy, which develops during the course of Diabetes Mellitus (DM), significantly affects patients' quality of life, making its early diagnosis and detection crucial. Furthermore, it is thought that the impact of neuropathy developing in the course of DM is not localized but has systemic effects. In our study, we will investigate the role of evaluating hemogram parameters and systemic effects in predicting the risk and monitoring the course of diabetic neuropathy in patients followed up with DM.
Methods: Data from patients who presented to the xxx University Neurology outpatient clinic between 2024 and 2025 will be scanned. This will include patients diagnosed with diabetic neuropathy and Diabetes Mellitus, as well as those investigated for but not found to have neuropathy. One hundred individuals will be included in each group. Group 1 was defined as 50 individuals with a diagnosis of diabetic neuropathy, and Group 2 as 50 individuals without a diagnosis of diabetic neuropathy. Within the scope of the study, the following data will be recorded from the hospital data system: patients' age, gender, past medical histories, diagnoses, treatments received, and laboratory test results including hemogram, HbA1c, glucose, sedimentation, CRP, ALT, AST, BUN, creatinine, B12, vitamin D, folic acid, ferritin, and electrolyte levels. The ratios of neutrophil, platelet, and monocyte counts to lymphocytes will be calculated and analyzed to assess their association with neuropathy. The data will be analyzed using SPSS, with the significance level set at 0.005.
Results: Of the 100 individuals included in the study, 61 (55.5%) were female and 39 (35.5%) were male; the mean age was calculated as 45.77 ± 17.48. The 50 individuals with diabetic polyneuropathy and the 50 individuals in the healthy control group were analyzed as two groups. Among the 100 patient individuals, 44 (48.9%) were within the target HbA1c range, while 46 (51.1%) individuals were observed to have uncontrolled DM. No statistically significant difference was observed between the groups in terms of fasting blood glucose and HbA1c levels (p=0.657). While no statistically significant difference was observed in NLR and PLR, calculated from the same hemogram data in Group 1 and Group 2 (p=0.647 and p=0.242, respectively), the difference in MLR was found to be statistically significant (p=0.0024).
Conclusion: Although diabetic neuropathy presents with localized symptoms, its effects are systemic. The monocyte-to-lymphocyte ratio (MLR) was evaluated as a usable parameter for the early detection of developing neuropathy and for determining neuropathy risk. Its correlation with next-generation inflammatory biomarkers may be required. As hemogram data is a test that is available and feasible to perform in most medical centers, it could be a suitable tool for monitoring the development of neuropathy in DM patients, and potentially for post-treatment follow-up.

Keywords : Diabetes mellitus, diabetic neuropathy, neutrophil, lymphocyte, monocyte

Download Article


1. American Diabetes Association Professional Practice Committee. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17-S38. doi:10.2337/dc 22-S002
2. TEMD Diyabet Bilimsel Çalışma Grubu. Diabetes mellitus ve komplikasyonlarının tanı, tedavi ve izlem kılavuzu. TEMD. 2024.
3. Anaforoğlu İ. Diyabet ve sinir sistemi: periferik ve otonom nöropati. Turk J Endocrinol Metab. 2023;16(2):40-48.
4. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26(3):917-932. doi:10.2337/diacare.26.3.917
5. Strand N, Anderson MA, Attanti S, et al. Diabetic neuropathy: pathophysiology review. Curr Pain Headache Rep. 2024;28(6):481-487. doi:10.1007/s11916-024-01243-5
6. Wang W, Ji Q, Ran X, et al. Prevalence and risk factors of diabetic peripheral neuropathy: a population-based cross-sectional study in China. Diabetes Metab Res Rev. 2023;39(8):e3702. doi:10.1002/dmrr.3702
7. Sun X, Yang X, Zhu X, et al. Association of vitamin D deficiency and subclinical diabetic peripheral neuropathy in type 2 diabetes patients. Front Endocrinol (Lausanne). 2024;15:1354511. doi:10.3389/fendo.2024. 1354511
8. Akin A. Diyabetli hastalarda diyabetik periferal nöropati ile ilişkili faktörlerin değerlendirilmesi. Sakarya Med J. 2024;14(4):344-353. doi: 10.31832/smj.1528013
9. TEMD Dislipidemi Çalışma Grubu. Diyabetik dislipidemi ve tedavisi. In: Tani ve Tedavi Kılavuzu. TEMD; 2021.
10. Karacaer NT, Tuncer SÇ. Tip 2 diyabetik hastalarda glisemik kontrolün D vitamini, B12 vitamini ve lipid profili üzerine etkilerinin araştırılması: bir retrospektif çalışma. Aksaray Univ Tip Bilim Derg. 2023;3(3):10-14.
11. Özütemiz AÖ. Tip 2 diabetes mellitus tanılı hastalarda nötrofil lenfosit ve trombosit lenfosit oranı ve komplikasyonlarla ilişkisi [doctoral thesis]. İzmir, Türkiye: Dokuz Eylül Üniversitesi; 2016.
12. Tuncer T, Karakeçi ES. Diyabetik nöropatide yeni inflamatuar indeksler. Turk J Phys Med Rehabil Sci. 2025;28(2):150-155.
13. Çelikdelen SÖ, Günay A, Aydemir Ö, Aksu O. Tip 2 diyabetli hastalarda nötrofil/lenfosit oranı ve sistemik inflamasyon indeksinin mikroalbuminüri ile ilişkisinin değerlendirilmesi. Süleyman Demirel Univ Saglik Bilim Derg. 2024;15(3):437-446. doi:10.22312/sdusbed. 1378954
14. Hao X, Li D, Wu D, et al. The relationship between hematological indices and autoimmune rheumatic diseases (ARDs): a meta-analysis. Sci Rep. 2017;7:10833. doi:10.1038/s41598-017-11398-4
15. Yang Z, Zhang Z, Lin F, et al. Comparisons of neutrophil-, monocyte-, eosinophil-, and basophil-lymphocyte ratios among various systemic autoimmune rheumatic diseases. APMIS. 2017;125(10):863-871. doi:10. 1111/apm.12722
16. Peirovy A, Malek Mahdavi A, Khabbazi A, et al. Clinical usefulness of hematologic indices as predictive parameters for systemic lupus erythematosus. Lab Med. 2020;51(5):519-528. doi:10.1093/labmed/lmaa009
17. Ayna AB, Ermurat S, Coşkun BN, et al. Neutrophil to lymphocyte ratio and mean platelet volume as inflammatory indicators in systemic lupus erythematosus nephritis. Arch Rheumatol. 2016;32(1):21-25. doi:10. 5606/ArchRheumatol.2017.5743
18. Geng Y, Zhu D, Wu C, et al. A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma. Int Immunopharmacol. 2018;65: 503-510. doi:10.1016/j.intimp.2018.10.002
19. Xie QK, Chen P, Hu WM, et al. The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor. J Transl Med. 2018;16(1):273. doi:10.1186/s12967-018-1634-0
20. Pop-Busui R, Ang L, Holmes C, et al. Inflammation as a therapeutic target for diabetic neuropathies. Curr Diab Rep. 2016;16(3):29. doi:10. 1007/s11892-016-0727-5
21. Liu J, Liu X, Li Y, et al. The association of neutrophil to lymphocyte ratio, mean platelet volume, and platelet distribution width with diabetic retinopathy and nephropathy: a meta-analysis. Biosci Rep. 2018;38(3):BSR20180172. doi:10.1042/BSR20180172
22. Hofmann MA, Schiekofer S, Kanitz M, et al. Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care. 1998;21(8):1310-1316. doi:10.2337/diacare.21.8.1310
23. Korpinen E, Groop PH, Fagerudd JA, et al. Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with type 1 diabetes mellitus with diabetic nephropathy. Diabet Med. 2001;18(2): 121-125. doi:10.1046/j.1464-5491.2001.00430.x
24. Broome DT, Pantalone KM, Kashyap SR, Philipson LH. Approach to the patient with MODY-monogenic diabetes. J Clin Endocrinol Metab. 2021;106(1):237-250. doi:10.1210/clinem/dgaa710
25. Öztürk A. Tip 2 diyabetes mellituslu hastalarda mikroalbuminüri ile nötrofil/lenfosit oranı arasındaki ilişki [doctoral thesis]. İstanbul, Türkiye: Bezmialem Vakıf Üniversitesi; 2023.
26. Doğan L, Özer Ö, Güçlü E. The effect of systemic inflammatory biomarkers and dyslipidemia on the prognosis of diabetic retinopathy in patients with type 2 diabetes mellitus: retrospective research. Turk J Ophthalmol. 2024;33(4):219-228. doi:10.5336/ophthal.2024-103341
27. Turan S. İnsülin direncinin lenfosit morfolojisi üzerinden değerlendirilmesi [master’s thesis]. İstanbul, Türkiye: Biruni Üniversitesi; 2022.
28. Sözel H, Avşar E, Alemdar MS, Aydemir M. Diyabetik süreçte monosit/HDL-kolesterol ve nötrofil/HDL-kolesterol oranları. İzmir Eğit Araşt Hast Tip Derg. 2022;26(1):19-29.
Article available in :
Volume 2, Issue 3, 2025
Page : 50-55
https://doi.org/10.51271/AJNN-0033
Article Information
Received : 16 Ağu 2025
Accepted : 18 Eyl 2025
Published : 30 Eyl 2025
Corresponding Author :

Güneş Seda Albayrak: Department of Neurology, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkiye

[email protected]
Citation : Albayrak GS, Felek D. The role of hemogram parameters in predicting diabetic neuropathy risk in patients follow-up with type 2 diabetes mellitus. Acad J Neurol Neurosurg. 2025;2(3):50-55.

Read: 6
Download : 5
Cited: 0
_Footer